(Z)-2-methyl-3-pyrazin-2-yl-3-sulfanylprop-2-enethioic S-acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: (Z)-2-methyl-3-pyrazin-2-yl-3-sulfanylprop-2-enethioic S-acid
• 化学式: C₈H₈N₂OS₂
• 分子量: 212.3
• InChiKey: JDRRNNZSLICJTN-ALCCZGGFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  44.8
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING MUCOSITIS AND WEIGHT LOSS
  申请人：Prendergast Patrick T.

  公开号：US20100092547A1

  公开（公告）日：2010-04-15

  A method for prophylaxis and/or treatment of mucositis comprising the steps of providing a therapeutically effective amount of a composition comprising either (1) at least one compound selected from the group consisting of 5-[2-pyrazinyl]-4-methyl-1,2-3-thione or an analogue, derivative, metabolite, prodrug, solvate or a pharmaceutically acceptable salt thereof; or (2) a cytokinin compound; and administering the composition to a subject in need of such treatment. Also provided are pharmaceutical compositions comprising 5-[2-pyrazinyl]-4-methyl-1,2-3-thione and/or a cytokinin compound and use of these compositions in the preparation of a medicament for the treatment and/or prophylaxis of mucositis. The cytokinin compound may be selected from, but is not limited to N 6 -isopentenyl adenosine and N 6 -benzyl adenosine. The compositions may further comprise a chemotherapeutic agent, such as cisplatin. Further provided are methods and compositions for reducing and/or preventing weight loss in subjects undergoing cancer treatment.
• COMPOSITIONS AND METHODS FOR MODULATING THE IMMUNE SYSTEM
  申请人：Prendergast Patrick T.

  公开号：US20120196825A1

  公开（公告）日：2012-08-02

  The present invention provides methods and compositions for the prophylaxis of blood cell disorders such as neutropenia, thrombocytopenia, lymphocytopenia, and anaemia. The invention provides methods wherein compositions comprising at least one cytokinin compound are administered either therapeutically or prophylactically. The invention further has utility in methods of DNA repair.
• Compositions and Methods for Preventing and Treating Mucositis and Weight Loss
  申请人：Cascade Estate Ltd.

  公开号：US20130259930A1

  公开（公告）日：2013-10-03

  Pharmaceutical compositions comprising 5-[2-pyrazinyl]-4-methyl-1,2-3-thione or an analogue, derivative, metabolite, prodrug, solvate or a pharmaceutically acceptable salt thereof; and a pharmaceutical carrier, which promotes association with the outer wall of a subject's digestive tract are described as well as their uses in treating and preventing mucositis and cachexia.
• [EN] COMPOSITIONS AND METHODS FOR MODULATING THE IMMUNE SYSTEM<br/>[FR] COMPOSITIONS ET MÉTHODES POUR MODULER LE SYSTÈME IMMUNITAIRE
  申请人：PRENDERGAST PATRICK T

  公开号：WO2007131973A2

  公开（公告）日：2007-11-22

  [EN] The present invention provides methods and compositions for the prophylaxis of blood cell disorders such as neutropenia, thrombocytopenia, lymphocytopenia, and anaemia. The invention provides methods wherein compositions comprising at least one cytokinin compound are administered either therapeutically or prophylactically. The invention further has utility in methods of DNA repair.
  [FR] La présente invention concerne des méthodes et des compositions de prophylaxie de troubles cellulaires sanguins tels que de neutropénie, thrombocytopénie, lymphocytopénie et anémie. L'invention concerne des méthodes selon lesquelles des compositions comprenant au moins un composé cytokinine sont administrées soit thérapeutiquement, soit prophylactiquement. L'invention est en outre utile dans des méthodes de réparation d'ADN.
• [EN] COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING MUCOSITIS AND WEIGHT LOSS<br/>[FR] COMPOSITIONS ET PROCÉDÉS POUR PRÉVENIR ET TRAITER L'INFLAMMATION D'UNE MUQUEUSE ET LA PERTE DE POIDS
  申请人：PRENDERGAST PATRICK T

  公开号：WO2008110585A2

  公开（公告）日：2008-09-18

  [EN] A method for prophylaxis and/or treatment of mucositis comprising the steps of providing a therapeutically effective amount of a composition comprising either (1) at least one compound selected from the group consisting of 5-[2-pyrazinyl]-4-methyl-1,2-3-thione or an analogue, derivative, metabolite, prodrug, solvate or a pharmaceutically acceptable salt thereof; or (2) a cytokinin compound; and administering the composition to a subject in need of such treatment. Also provided are pharmaceutical compositions comprising 5-[2-pyrazinyl]-4-methyl-1,2-3- thione and/or a cytokinin compound and use of these compositions in the preparation of a medicament for the treatment and/or prophylaxis of mucositis. The cytokinin compound may be selected from, but is not limited to N⁶-isopentenyl adenosine and N⁶-benzyl adenosine. The compositions may further comprise a chemotherapeutic agent, such as cisplatin. Further provided are methods and compositions for reducing and/or preventing weight loss in subjects undergoing cancer treatment.
  [FR] L'invention porte sur un procédé pour la prophylaxie et/ou le traitement de l'inflammation d'une muqueuse comprenant les étapes consistant à se procurer une quantité thérapeutiquement efficace d'une composition comprenant soit (1) au moins un composé choisi dans le groupe constitué par le 5-[2-pyrazinyl]-4-méthyl-1,2-3-thione ou un analogue, dérivé, métabolite, promédicament, solvate ou sel pharmaceutiquement acceptable de celui-ci; soit (2) un composé cytokinine; et à administrer la composition à un sujet nécessitant un tel traitement. L'invention porte également sur des compositions pharmaceutiques comprenant le 5-[2-pyrazinyl]-4-méthyl-1,2-3-thione et/ou un composé cytokinine et sur une utilisation de ces compositions dans la préparation d'un médicament pour le traitement et/ou la prophylaxie de l'inflammation d'une muqueuse. Le composé cytokinine peut être sélectionné parmi, mais sans y être limité, la N⁶-isopentényl adénosine et la N⁶-benzyl adénosine. Les compositions peuvent en outre comprendre un agent chimiothérapeutique, tel que la cisplatine. L'invention porte en outre sur des procédés et des compositions pour réduire et/ou prévenir la perte de poids dans des sujets subissant un traitement du cancer.